SEC Form 4 · accession 0001078782-17-001647
Zivo Bioscience, Inc. · ZIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher D. Maggiore
Director · 10% Owner
Period of report
Nov 24, 2017
Accepted (ET)
Nov 29, 2017 · 5:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101026
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 24, 2017 | P | 80,000 | $0.09 | A | 13,895,831 | D | |
| Common Stock | Nov 27, 2017 | P | 33,000 | $0.09 | A | 13,928,831 | D | |
| Common Stock | Nov 28, 2017 | P | 81,500 | $0.11 | A | 14,010,831 | D | |
| Common Stock | Nov 29, 2017 | P | 2,500 | $0.15 | A | 14,012,831 | D |
Table II — derivative securities
No Table II lines on this filing.